Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pilot phase II study of estradiol [TX-004HR] in postmenopausal women with vulvar and vaginal atrophy

Next Previous
Trial Profile

A pilot phase II study of estradiol [TX-004HR] in postmenopausal women with vulvar and vaginal atrophy

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol (Primary)
  • Indications Atrophic vaginitis
  • Focus Therapeutic Use

Most Recent Events

  • 06 Oct 2018 Results assessing the physical characteristics of TX-004HR in this study, two phase 1 studies and an in-vitro study, presented at the North American Menopause Society 2018 Annual Meeting
  • 22 Sep 2016 According to a TherapeuticsMD media release, data of this trial will be presented at annual meetings of the International Menopause Society (IMS) and the North American Menopause Society (NAMS), 2016.
  • 09 Mar 2015 Results published in TherapeuticsMD media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top